Reprogramming the immunosuppressive tumor microenvironment

A key pathway through which tumors evade the immune system is the reprogramming of cellular constituents of the tumor microenvironment (TME) towards an ...

Reprogramming the immunosuppressive tumor microenvironment ...

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD- ...

Reprogramming the immunosuppressive tumor microenvironment ...

Nanomedicine with excellent targetability offers a novel approach to improving cancer immunotherapy via metabolically reprogramming the immunosuppressive TME.

Reprogramming the immunosuppressive tumor microenvironment ...

Increasing evidence indicates that immunotherapy is hindered by a hostile tumor microenvironment (TME) featured with deprivation of critical ...

Reprogramming the tumor immune microenvironment using ... - Nature

We report a method of targeted immunotherapy using an attenuated Salmonella typhimurium (SAM-FC) engineered to release dual payloads.

Reprogramming the immunosuppressive tumor microenvironment ...

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1.

Vascular normalizing doses of antiangiogenic treatment reprogram ...

The recent approval of a prostate cancer vaccine has renewed hope for anticancer immunotherapies. However, the immunosuppressive tumor microenvironment may ...

Reprogramming the Tumor Microenvironment to Improve ...

Reprogramming specific facets of the immune compartment, such as immunosuppressive myeloid and lymphoid cell subsets, may overcome ...

Corrigendum: Reprogramming the immunosuppressive tumor ...

These pathways also interact with various cells of the tumor immune microenvironment to facilitate tumor immune evasion and immunotherapy ...

Fighting Immune Cold and Reprogramming Immunosuppressive ...

However, how to comprehensively inhibit the immunosuppressive tumor microenvironment (TME) remains a major challenge for immunotherapy to ...

Reprogramming the tumor microenvironment by genome editing for ...

The tumor microenvironment (TME) is essential for immune escape by tumor cells. It plays essential roles in tumor development and metastasis ...

Tumor microenvironment reprogramming by nanomedicine to ...

The use of multidrug combinations to improve the TME is an efficient approach to boosting the effectiveness of antitumor immune responses. Therefore, ...

Reprogramming the Tumor Immune Microenvironment - Cell Press

This collection showcases exciting research on reprogramming the tumor immune microenvironment.

Ultra-efficient radio-immunotherapy for reprogramming the hypoxic ...

Ultra-efficient radio-immunotherapy for reprogramming the hypoxic and immunosuppressive tumor microenvironment with durable innate immune memory. Author ...

Metabolic reprogramming and immune evasion - Biomarker Research

... immune system attacks, primarily through metabolic reprogramming, which significantly alters the tumor microenvironment (TME) to modulate immune

Nanoengineered Immune Niches for Reprogramming the ...

For most patients, the therapeutic efficacy of cancer immunotherapy is mainly limited by the immunosuppressive tumor microenvironment (TME). To ...

Reprogramming immunosuppressive myeloid cells by activated T ...

These cells often accumulate in tumors, playing a crucial role in the immunosuppressive tumor microenvironment (TME). MDSCs inhibit the anti ...

Nanodrug regulates lactic acid metabolism to reprogram the ...

A majority of cancers fail to respond to immunotherapy due to the immunosuppressive tumor microenvironment (TME), and metabolic regulation of the TME has ...

The Tumor Microenvironment Reprograms Immune Cells

Tumor cells reprogram immune cells and other stromal cells in the TME to constrain their antitumor capacity by creating an immunosuppressive milieu and ...

Reprogramming Tumor Immune Microenvironment (TIME) and ...

A mannosylated lactoferrin nanoparticulate system (Man-LF NPs) is developed for dual-targeting biomimetic codelivery of shikonin and JQ1 via the mannose ...